AO R-Pharm (part of the R-Pharm group of companies) is investing more than 4 billion rubles in the construction of the production of medicines in St. Petersburg, according to the press service of the Office of the Governor of the city.
In particular, 2.9 billion rubles will be allocated for the construction of the plant and procuring equipment, and 1.2 billion rubles for R&D and technology deployment.
Earlier, GxP News wrote that R-Pharm plans to build drug manufacturing facilities in St. Petersburg by 2026 under the first offset contract. In January, the government of St. Petersburg and R-Pharm signed a contract for 10 years. Under the terms of the contract, the city authorities will purchase drugs from the company for a total of 8.7 billion rubles for seven years after the completion of the construction.
According to the project, the company is expected to make 31 pharmaceutical products, including generics for the treatment of cancer, cardiovascular and neurological diseases, and diabetes.